EDGAR Filing Documents for 0001193125-15-300371

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-15-300371

Filing Date

2015-08-24

Accepted

2015-08-24 16:59:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	d22668ds3.htm	S-3	452368
2	EX-4.4	d22668dex44.htm	EX-4.4	248420
3	EX-4.7	d22668dex47.htm	EX-4.7	252195
4	EX-5.1	d22668dex51.htm	EX-5.1	15122
5	EX-23.2	d22668dex232.htm	EX-23.2	2003
	Complete submission text file	0001193125-15-300371.txt		971291

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421

Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904

Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)